Compare Regeneron Pharmaceuticals Inc (REGN) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs Southern Copper Corp — how do they compare? Regeneron Pharmaceuticals Inc trades at $739.58 (market cap $76.40B), while Southern Copper Corp trades at $202.3 (market cap $169.35B). The key difference: Southern Copper Corp is far larger — about 2.2× Regeneron Pharmaceuticals Inc's market cap, and Southern Copper Corp pays the higher dividend (2.19%). Which is the better fit depends on your goals — on Pluang, investors hold Regeneron Pharmaceuticals Inc for 107 Days and Southern Copper Corp for 61 Days on average.
| REGN | SCCO | |
|---|---|---|
Market Cap | $76.40B | $169.35B |
Volume | 626,381 | 719,187 |
Sector | Health | Basic Materials |
52-Week High | $852.03 | $219.70 |
52-Week Low | $557.73 | $120.02 |
Typical Hold Time | 107 Days | 61 Days |
Enterprise Value | $71.12B | $170.64B |
Dividend Yield | 0.51% | 2.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Regeneron Pharmaceuticals (REGN) trades at $739.57, up 0.12% on the day, with a bearish technical signal but strong fundamental performance. Recent earnings have consistently beaten estimates, and the company maintains robust profitability with a net income margin of 27.86%. A major $8 billion expansion of the immunology alliance with Sanofi, announced October 1, 2026, provides significant future revenue potential and strategic momentum.
The outlook is positive, supported by strong earnings, a lucrative partnership, and a consensus analyst price target of $846. Key risks include competitive pressures in key drug markets and reliance on successful clinical trial outcomes. The stock presents a compelling opportunity for growth investors, though volatility may persist near-term.
Southern Copper (SCCO) trades at $198.66, down 2.74% amid broader copper sector weakness. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $1.99 versus $1.94 forecast, continuing a trend of earnings outperformance. Revenue growth accelerated to $13.42B in 2025 with net margins expanding to 35.87%, while technical indicators remain neutral with support at $196. The company maintains robust profitability with 50.07% ROE and recently announced a $1.10 dividend payable August 27, 2026.
SCCO presents a mixed investment case with exceptional profitability metrics offset by premium valuations (P/E 30.1) and analyst skepticism. Near-term catalysts include Q3 earnings due soon and continued execution on $10.2B Mexican growth projects. Primary risks involve copper price volatility and valuation concerns highlighted by Seeking Alpha's premium assessment. Despite 10.34% buy ratings, the consensus price target of $164.33 suggests 17% downside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
